Stay updated on MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision entry v3.4.2 was added to the history and the previous revision v3.4.1 was removed. This appears to be a metadata/UI update to the page's revision history rather than a change to study data or functionality.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and v3.4.0 was removed in the history, indicating a minor system update.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page history adds a new Revision: v3.3.4 entry and removes Revision: v3.3.3, reflecting a minor internal version update to the record history UI.SummaryDifference0.1%

- Check63 days agoChange DetectedThe changes are minor site maintenance updates: a new footer revision note 'Revision: v3.3.3' was added, and the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' links were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision history now shows an added entry for v3.3.2 and removal of v3.2.0, with no changes to study data or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check99 days agoChange DetectedThe government funding lapse notice banner at the top of the page was removed, while the version history and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MOUNTAINEER-02: Tucatinib Combo in HER2+ Gastric Cancer Clinical Trial page.